Fluorescence Immunoassay (FIA)
Chemiluminescence Immunoassay (CLIA)
Rapid Test (Colloidal gold)
Quality Control
Chest Pain Center
Stroke Center
Trauma Center
Critical Maternal Care Center
Critical Children and Neonatal Care Center
Center for Reproductive Medicine
Hierarchical diagnosis and treatment
Hospital-wide solution
Jul 26,2022
19 Product Registration Certificate (NMPA)! Guangdong Weishi Bio-Immunofluorescence Latest Product Summary
Aug 19,2022
Set sail for a new journey! Guangdong Weishi Biology and National Clinical Medical Research Center for Nervous System Diseases reach strategic cooperation in CHANCE-3 project
Aug 30,2022
2021.10~2022.6 Solid Waste Pollution Prevention and Control Information Disclosure
Sep 16,2022
Multi-law, multi-application scenarios! Guangdong Weishi Biological Innovation Upgrade IVD Technology Platform Helps "Healthy China" Action
Oct 08,2022
World Heart Day | professional know "heart", science and technology to protect the "heart"!
Oct 27,2022
Set sail, create a better future! Guangdong Weishi Bio Brings New Products to CACLP 2022
Nov 08,2022
Solid waste pollution prevention and control information disclosure in 2022 (third quarter)
Nov 15,2022
More than 50% of Chinese adults have diabetes or are in the pre-disease stage. See here for diagnostic criteria.
Nov 21,2022
"Only" innovation, win the future! Guangdong Weishi biological new products unveiled in 2022 Germany MEDICA medical exhibition
Nov 24,2022
Together, set sail-Guangdong only real biological new corporate promotional film officially released!